Rapid Development of Autoimmune Hepatitis Secondary to Minocycline
Open Access
- 10 March 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23038
Abstract
Autoimmune hepatitis (AIH) is a condition that affects the liver which, potentially, may render it fibrotic and eventually cirrhotic. This condition has many etiologies ranging from genetic predispositions and immunological defects to medication and environmental side effects. Essentially, we will explore the risks, presentation, diagnosis, and treatment of this condition as it relates to a medication-induced etiology. Here we report a case where a patient developed this condition from taking the antibiotic minocycline. The patient was treated with prednisone therapy and went into complete remission with no reoccurrence of AIH. The purpose of this case report is to highlight the fact that these cases have the potential to occur fairly sooner than expected, in a matter of weeks or months, after the induction of minocycline. Hence, carefully monitoring liver functions more frequently may aide in the prevention of minocycline-induced AIH.Keywords
This publication has 7 references indexed in Scilit:
- Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019Journal of Clinical Gastroenterology, 2020
- Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune HepatitisPediatric Gastroenterology, Hepatology & Nutrition, 2018
- Autoimmune hepatitis: HistopathologyClinical Liver Disease, 2014
- Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre studyLiver International, 2013
- Letter: Tetracycline-induced hepatotoxicity.2011
- Tetracycline-induced hepatotoxicityDermatology Online Journal, 2011
- Simplified criteria for the diagnosis of autoimmune hepatitis†Hepatology, 2008